Fingerprint
Dive into the research topics of 'Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically